D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.
about
Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative reviewAugmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disordersD-Cycloserine in Neuropsychiatric Diseases: A Systematic ReviewFrom the neurobiology of extinction to improved clinical treatments.Individual differences in recovery from traumatic fearSleep and REM sleep disturbance in the pathophysiology of PTSD: the role of extinction memory.Towards new approaches to disorders of fear and anxiety.Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variablesA randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysisD-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.Implications of memory modulation for post-traumatic stress and fear disorders.Advancing psychotherapy and evidence-based psychological interventions.Multistage drug effects of ketamine in the treatment of major depression.A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment.The NMDA receptor partial agonist d-cycloserine does not enhance motor learningTransdiagnostic treatment for anxiety and depression.Optimizing the efficacy of exposure in PTSD treatment.EJPT abstract book for Special issue: Psychotrauma update.
P2860
Q22305514-386084D3-4D05-45DB-B057-D41218F95230Q24187995-B1A35C65-C59A-4605-8A91-E6D1BB2963F9Q26781321-655E9F0F-6B8A-40E7-A001-B0717C2D8CEAQ27011901-E9B94BAB-4502-4C97-931D-98EA6E0999E4Q28389310-61AFF503-6D29-4D2E-8ADE-E6FD62F080AAQ30410039-0788CF5D-6F74-4F29-B9C6-ECA3013BF22EQ30437494-02E2C04B-8E28-4B1F-9A9C-BF621B05FB3AQ31171981-D0B62D6B-4D24-4A9E-A1F2-9265609B6241Q34017493-A7AD7CF9-690C-43F3-88B2-D7FDB47268C5Q34500045-190F2F0B-AE24-4A9B-BADF-6FA997CDF38CQ34562562-ACCF21EB-0B23-491B-BE6B-2F7DD426C7B8Q34729257-8C000DCE-ED3D-4886-A237-DC8104E8B203Q35541703-44D1C286-314B-4DCE-B106-88063F6A86A8Q36304362-1C30AF5C-EDBF-4C9C-868C-6B5D8A72E179Q36948459-3EF322E3-0501-4FB7-A9B7-34CE2D8B3A16Q37118033-7D553D3C-BCFA-4E01-B6DE-37A665D8E06EQ38174533-C2CEE7DA-3B65-4230-9748-25984DD6C012Q38248776-867A0913-68B8-4134-82E7-3F673996EBB4Q38851779-ADD33C29-46EE-45DB-8D5C-AC945ECCBF12Q38852116-CFA66B60-D907-4602-A3F5-9FF8781AD49EQ38858843-636E89A1-139D-4A9F-8557-3C41E911E22EQ41476154-1364F2FE-DDAB-4ACD-BB55-153BDD3DD28BQ45932992-4C5D5189-A6EE-4634-8574-E456AB43842FQ46705017-BCF35F2C-AA7E-4F43-BEC4-69E646C1A828Q50072741-AA789E23-EEB6-418E-B9E0-060049607CA7
P2860
D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
D-cycloserine augmentation of ...... ty disorders: a meta-analysis.
@ast
D-cycloserine augmentation of ...... ty disorders: a meta-analysis.
@en
type
label
D-cycloserine augmentation of ...... ty disorders: a meta-analysis.
@ast
D-cycloserine augmentation of ...... ty disorders: a meta-analysis.
@en
prefLabel
D-cycloserine augmentation of ...... ty disorders: a meta-analysis.
@ast
D-cycloserine augmentation of ...... ty disorders: a meta-analysis.
@en
P2860
P356
P1476
D-cycloserine augmentation of ...... ety disorders: a meta-analysis
@en
P2093
Kaitlyn E Panza
Michael H Bloch
P2860
P304
P356
10.4088/JCP.11R07356
P577
2012-04-01T00:00:00Z